Microbix names Jim Currie as CFO

Microbix Biosystems (TSX:MBX) appointed Jim Currie as CFO, succeeding Charles Wallace, who is retiring at the end of the year.

Mr. Currie was most recently CFO of SMTC, a global electronics manufacturing services company. Previously, he was VP of finance at MDS SCIEX, a global leader in life science and analytical technologies.

In a statement, Vaughn Embro-Pantalony, president and CEO of Microbix, said Mr. Wallace was instrumental in helping the company improve its financial position in recent years. “And I welcome Jim to Microbix and to the leadership team. We look forward to working with him as we continue to focus on driving the growth of our company.”


Sign up to our weekly BioTuesdays newsletter.